$19.82
6.86% day before yesterday
Nasdaq, May 30, 10:00 pm CET
ISIN
US8753722037
Symbol
TNDM

Tandem Diabetes Care, Inc. Stock price

$19.82
+2.97 17.63% 1M
-12.69 39.03% 6M
-16.20 44.98% YTD
-33.61 62.90% 1Y
-50.99 72.01% 3Y
-64.87 76.60% 5Y
-103.38 83.91% 10Y
Nasdaq, Closing price Fri, May 30 2025
-1.46 6.86%
ISIN
US8753722037
Symbol
TNDM
Sector

Key metrics

Market capitalization $1.32b
Enterprise Value $1.31b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.33
P/S ratio (TTM) P/S ratio 1.34
P/B ratio (TTM) P/B ratio 8.50
Revenue growth (TTM) Revenue growth 27.66%
Revenue (TTM) Revenue $982.95m
EBIT (operating result TTM) EBIT $-91.94m
Free Cash Flow (TTM) Free Cash Flow $-50.20m
Cash position $368.63m
EPS (TTM) EPS $-2.78
P/E forward negative
P/S forward 1.31
EV/Sales forward 1.30
Short interest 16.12%
Show more

Is Tandem Diabetes Care, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Tandem Diabetes Care, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

11x Buy
46%
12x Hold
50%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

Buy
46%
Hold
50%
Sell
4%

Financial data from Tandem Diabetes Care, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
983 983
28% 28%
100%
- Direct Costs 470 470
20% 20%
48%
513 513
35% 35%
52%
- Selling and Administrative Expenses 405 405
15% 15%
41%
- Research and Development Expense 201 201
15% 15%
20%
-75 -75
43% 43%
-8%
- Depreciation and Amortization 17 17
3% 3%
2%
EBIT (Operating Income) EBIT -92 -92
37% 37%
-9%
Net Profit -184 -184
30% 30%
-19%

In millions USD.

Don't miss a Thing! We will send you all news about Tandem Diabetes Care, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tandem Diabetes Care, Inc. Stock News

Neutral
Business Wire
26 days ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025 at 10:00am Eastern Time (7:00am Pacific Time), Jefferies Global Healthcare Conference ...
Neutral
Seeking Alpha
about one month ago
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - President & CEO Leigh Vosseller - EVP & CFO Conference Call Participants Matt Miksic - Barclays Mat Blackman - Stifel Steve Lichtman - Oppenheimer & Company Matthew O'Brien - Piper Sandler David Roman - Gold...
Neutral
Business Wire
about one month ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights, Financial Results Compared to First Quarter 2024 Achieved record first quarter sales with worldwide growth of 22% Increased pump sales in the United States by 19...
More Tandem Diabetes Care, Inc. News

Company Profile

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Head office United States
CEO John Sheridan
Employees 2,650
Founded 2006
Website www.tandemdiabetes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today